p38α-IN-13
p38α-IN-13 is p38α MAPK, BChE and AChE inhibitor with IC50 values of 5.79, 16.24, 51.8 µM for p38α MAP, hBChE, hAChE, respectively. p38α-IN-13 has the potential for the research of Alzheimer’s disease.
For research use only. We do not sell to patients.
- CAS No.: 3077831-12-7
- Formula: C22H26F2N4O2
- Molecular Weight:416.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
p38α MAPK 5.79 μM (IC50) |
hBCHE 16.24 μM (IC50) |
hAChE 51.8 μM (IC50) |
In Vitro
p38α-IN-13 (5-(2,4-difluorophenoxy)-N-(2-(dimethylamino)ethyl)-2-isobutyl-2H-indazole-6-carboxamide) is a p38α MAPK, BChE and AChE inhibitor[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 3077831-12-7
-
Molecular Weight 416.46
-
Formula C22H26F2N4O2
-
SMILES
O=C(C1=CC2=NN(CC(C)C)C=C2C=C1OC3=CC=C(F)C=C3F)NCCN(C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)